Drug search by name

Oxaliplatin Intravenous and Thrombocytopenia

Result of checking the interaction of drug Oxaliplatin Intravenous and disease Thrombocytopenia for safety when used together.

Check result:

Oxaliplatin Intravenous <> Thrombocytopenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thrombocytopenia was frequently reported with the combination of oxaliplatin and infusional 5-FU/LV. Therapy with oxaliplatin should be administered cautiously in patients whose bone marrow reserve may be severely depressed by prior chemotherapy or irradiation, whose marrow function is recovering from previous cytotoxic therapy, or in patients with compromised renal function. Patients should be instructed to immediately report any signs or symptoms suggesting bleeding such as petechia, purpura, epistaxis, hemoptysis, hematuria, and melena. Therapy with oxaliplatin should be administered cautiously in patients with compromised bone marrow reserve. Close clinical monitoring of hematopoietic function is recommended.

Oxaliplatin Intravenous

Generic Name: oxaliplatin

Brand Name: Eloxatin

Synonyms: Oxaliplatin

What is Oxaliplatin Intravenous?